Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
1,5- diaryl pyrazole-loaded chitosan nanoparticles as COX-2 inhibitors, mitigate neoplastic growth by regulating NF-κB pathway in-vivo zebrafish model.
Murugan R, Selvam M, Haridevamuthu B, Ashok K, Chagaleti BK, Priya D, Rajagopal R, Alfarhan A, Kumaradoss KM, Arockiaraj J. Murugan R, et al. Among authors: ashok k. Int J Biol Macromol. 2024 Nov 12:137599. doi: 10.1016/j.ijbiomac.2024.137599. Online ahead of print. Int J Biol Macromol. 2024. PMID: 39542324
Effectiveness of the original monovalent mRNA COVID-19 vaccination series against hospitalization for COVID-19-associated venous thromboembolism.
Hager DN, Zhu Y, Sohn I, Stubblefield WB, Streiff MB, Gaglani M, Steingrub JS, Duggal A, Felzer JR, O'Rourke M, Peltan ID, Mohamed A, Stiller R, Wilson JG, Qadir N, Ginde AA, Zepeski AE, Mallow C, Lauring AS, Johnson NJ, Gibbs KW, Kwon JH, Self WH; Investigating Respiratory Viruses in the Acutely Ill (IVY) Network. Hager DN, et al. J Infect Dis. 2024 Oct 15:jiae502. doi: 10.1093/infdis/jiae502. Online ahead of print. J Infect Dis. 2024. PMID: 39405261
COX-2 targeted therapy for diabetic foot ulcers using T7-enhanced CS-PVA membranes.
Murugan R, Ashok K, Ramya Ranjan Nayak SP, Deivasigamani P, Almutairi MH, Almutairi BO, Guru A, Muthu Kumaradoss K, Arockiaraj J. Murugan R, et al. Among authors: ashok k. Int Immunopharmacol. 2024 Dec 25;143(Pt 1):113206. doi: 10.1016/j.intimp.2024.113206. Epub 2024 Sep 30. Int Immunopharmacol. 2024. PMID: 39353389
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.
Jensen TO, Murray TA, Grandits GA, Jain MK, Grund B, Shaw-Saliba K, Matthay MA, Abassi M, Ardelt M, Baker JV, Chen P, Dewar RL, Goodman AL, Hatlen TJ, Highbarger HC, Holodniy M, Lallemand P, Laverdure S, Leshnower BG, Looney D, Moschopoulos CD, Mugerwa H, Murray DD, Mylonakis E, Nagy-Agren S, Rehman MT, Rupert A, Stevens R, Turville S, Weintrob A, Wick K, Lundgren J, Ko ER; ACTIV-3/TICO Study Group. Jensen TO, et al. Lancet Microbe. 2024 Jun;5(6):e559-e569. doi: 10.1016/S2666-5247(24)00015-6. Epub 2024 May 27. Lancet Microbe. 2024. PMID: 38815595 Free article. Clinical Trial.
120 results